Health Condition 1: K509- Crohns disease, unspecified
Conditions
Interventions
Intervention1: Vitamin D: Vitamin D is given to all the participant patients having IBD and evaluated the vitamin D level periodically every 3 months up to 1 year of time
Control Intervention1: Nil: N
Sponsors
Dr Mohamed Fiyas Konnola
Eligibility
Inclusion criteria
Inclusion criteria: Patients diagnosed with Crohns disease or ulcerative colitis based on clinical, endoscopic histological or radiological findings Participants aged between 14 and 65 years regardless of disease activity who have been receiving treatment for at least six months Willingness to undergo serum vitamin D level assessment Patients with or without ongoing treatment for IBD Both active disease and remission phases can be included as per validated activity indices Written informed consent to participate in the study Willingness to comply with followup visits and further assessments as per study protocol
Exclusion criteria
Exclusion criteria: Patients with chronic illnesses or autoimmune diseases unrelated to IBD Current or recent use of high-dose vitamin D supplements or other medications affecting vitamin D metabolism Patients with primary bone disorders like osteoporosis or osteomalacia not related to IBD. Presence of significant liver disease, renal disease, or cardiovascular conditions that could confound results. Pregnant or lactating women due to altered vitamin D metabolism. Conditions unrelated to IBD that may cause malabsorption (e.g., celiac disease, short bowel syndrome). Patients who have undergone major gastrointestinal surgery in the past 3 months. Patients unable to comply with the study protocol, follow-up visits, or assessments. History of alcohol or substance abuse that could interfere with study participation or data accuracy.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Impact of Vitamin D supplementation on IBDTimepoint: Baseline,12 weeks,24 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Adverse drug reaction of drugs Timepoint: Every two weeks for six weeks | — |
Countries
India
Contacts
Public ContactDr Mohamed Fiyas Konnola
BRD medical college
Outcome results
None listed